Accueil › Maladies pulmonaires › Massachusetts › Boston
Essais cliniques pour Maladies pulmonaires à Boston, MA
14 études pour Maladies pulmonaires recherchent des participants dans et autour de Boston (dans un rayon d'environ 30 miles). Ouvrez une étude pour voir qui peut participer et comment contacter l'équipe.
Texte officiel de l'étude (anglais)
Vous recrutez pour une étude ? Mettez-la en avant en haut de cette page — $99 pour 30 jours →
Neladalkib (NVL-655) for TKI-naive Patients With Advanced ALK-Positive NSCLC
Recrutement en coursPhase 3
- Dana-Farber Cancer Institute, Boston
A Study to Learn About a Study Medicine Called Ibuzatrelvir in Adult and Adolescent Patients With COVID-19 Who Are Not Hospitalized But Are at Risk For Severe Disease
Recrutement en coursPhase 3
- Brigham and Women's Hospital, Boston
A Study to Learn About the Study Medicine Ibuzatrelvir in Adults With COVID-19 Who Are Severely Immunocompromised
Recrutement en coursPhase 3
- Brigham and Women's Hospital, Boston
- Clinical Trials Center, Boston
- Clinical Trials Hub, Boston
A Study of Brenipatide (LY3537031) in Adult Participants With Moderate-to-Severe Chronic Obstructive Pulmonary Disease (COPD)
Recrutement en coursPhase 2
- Brigham and Women's Hospital, Boston
Study of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid Tumors
Recrutement en coursPhase 1/2
- Dana Farber Cancer Institute, Boston
A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer
Recrutement en coursPhase 3
- Boston Medical Center, Boston
A Study of Mosliciguat in Combination With Inhaled Treprostinil in PH-ILD
Recrutement en coursPhase 2
- Clinical Research Site, Boston
A Study of Zipalertinib in Patients With Advanced Non-Small Cell Lung Cancer With Epidermal Growth Factor Receptor (EGFR) Exon 20 Insertions or Other Uncommon Mutation.
Recrutement en coursPhase 2
- Beth Israel Deaconess Medical Center, Boston
A Phase II Study to Investigate Lung Function With 2 Different Doses of Inhaled Glycopyrronium Taken With BFF Compared to BFF in Participants of 4 to Less Than 12 Years of Age With Asthma
Recrutement en coursPhase 2
- Research Site, Boston
BElumosudil for Bronchiolitis Obliterans Prevention/Therapy (BEBOP)
Recrutement en coursPhase 2
- Dana-Farber Cancer Institute, Boston
- Boston Children's Hospital, Boston
- Brigham and Women's Hospital, Boston
A Study of Repotrectinib (TPX-0005) in Patients With Advanced Solid Tumors Harboring ALK, ROS1, or NTRK1-3 Rearrangements
Recrutement en coursPhase 1/2
- Massachusetts General Hospital,, Boston
Veterans Affairs Lung Cancer Surgery Or Stereotactic Radiotherapy
Recrutement en cours
- VA Boston Healthcare System Jamaica Plain Campus, Jamaica Plain, MA, Boston
A Study to Evaluate Vimseltinib in Adults With Active Chronic Graft-Versus-Host Disease (cGVHD)
Recrutement en coursPhase 2
- Dana-Farber Cancer Institute, Boston
Treatment of Pulmonary Arterial Hypertension Using the Aria CV Pulmonary Hypertension System
Recrutement en cours
- Brigham and Women's Hospital, Boston
Essais pour Maladies pulmonaires dans d'autres villes
- Houston, TX15 études
- Durham, NC13 études
- New York City, NY12 études
- Pittsburgh, PA11 études
- Dallas, TX10 études
- Nashville, TN10 études
- Columbus, OH10 études
- Los Angeles, CA10 études
- Washington, DC10 études
- Miami, FL10 études
- Ann Arbor, MI10 études
- Chicago, IL9 études
Autres études à Boston
- Cancer du sein111 études
- Cancer du poumon non à petites cellules90 études
- Cancer (tous types)86 études
- Cancer colorectal63 études
- Cancer métastatique63 études
- Cancer du poumon62 études
- Cancer de l'ovaire61 études
- Cancer de la prostate59 études
- Dépression52 études
- Cancer de l'endomètre50 études
- Insuffisance cardiaque44 études
- Leucémie aiguë myéloïde44 études
Source : ClinicalTrials.gov, données récupérées le 5 oct. 2026. Chaque étude définit ses propres critères d'éligibilité ; l'équipe de l'étude décide qui peut y participer.